New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 22  •  04:00PM ET
1.74
Dollar change
-0.03
Percentage change
-1.69
%
Index- P/E- EPS (ttm)-0.47 Insider Own- Shs Outstand551.86M Perf Week-9.29%
Market Cap960.24M Forward P/E- EPS next Y- Insider Trans- Shs Float22.85M Perf Month-5.43%
Enterprise Value786.12M PEG- EPS next Q- Inst Own0.03% Short Float0.15% Perf Quarter29.37%
Income-134.82M P/S65.01 EPS this Y- Inst Trans-17.67% Short Ratio0.94 Perf Half Y38.10%
Sales14.77M P/B4.82 EPS next Y- ROA-68.04% Short Interest0.03M Perf YTD27.94%
Book/sh0.36 P/C5.45 EPS next 5Y- ROE-79.90% 52W High2.35 -26.05% Perf Year86.60%
Cash/sh0.32 P/FCF941.41 EPS past 3/5Y17.63% 35.90% ROIC-67.69% 52W Low0.74 135.04% Perf 3Y70.59%
Dividend Est.- EV/EBITDA- Sales past 3/5Y35.10% 16.43% Gross Margin-1.90% Volatility7.89% 7.04% Perf 5Y10.84%
Dividend TTM- EV/Sales53.22 EPS Y/Y TTM-145.92% Oper. Margin-26.54% ATR (14)0.14 Perf 10Y-
Dividend Ex-DateAug 01, 2018 Quick Ratio14.18 Sales Y/Y TTM510.69% Profit Margin-912.89% RSI (14)47.55 Recom-
Dividend Gr. 3/5Y- - Current Ratio14.20 EPS Q/Q40.33% SMA20-2.22% Beta-0.66 Target Price4.00
Payout- Debt/Eq0.01 Sales Q/Q25.47% SMA50-2.11% Rel Volume0.04 Prev Close1.77
Employees27 LT Debt/Eq0.00 EarningsMar 28 BMO SMA20022.49% Avg Volume36.93K Price1.74
IPONov 03, 2017 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume1,486 Change-1.69%
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.